Skip to main content

Advertisement

SpringerLink
Log in

Rescue therapy with anti-CD20 treatment in neuroimmunologic breakthrough disease

  • LETTER TO THE EDITORS
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Martin F, Chan AC (2006) B cell immunobiology in disease: evolving concepts from the clinic. Annu Rev Immunol 24:467–496

    Article  CAS  PubMed  Google Scholar 

  2. Meinl E, Krumbholz M, Hohlfeld R (2006) B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation. Ann Neurol 59:880–892

    Article  CAS  PubMed  Google Scholar 

  3. Lassmann H, Bruck W, Lucchinetti C (2001) Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 7:115–121

    Article  CAS  PubMed  Google Scholar 

  4. Keegan M, König F, McClelland R, Brück W, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M, Parisi J, Lucchinetti CF (2005) Multiple sclerosis pathological subtype predicts treatment response to therapeutic plasma exchange. Lancet 366:579–582

    Article  PubMed  Google Scholar 

  5. Flachenecker P, Taleghani BM, Gold R, Grossmann R, Wiebecke D, Toyka KV (1998) Treatment of severe myasthenia gravis with protein A immunoadsorption and cyclophosphamide. Transfus Sci 19 (Suppl):43–46

    Article  PubMed  Google Scholar 

  6. Besinger UA, Toyka KV, Homberg M, Heininger K, Hohlfeld R, Fateh-Moghadam A (1983) Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity. Neurology 33:1316–1321

    CAS  PubMed  Google Scholar 

  7. Stuve O, Cepok S, Elias B, Saleh A, Hartung HP, Hemmer B, Kieseier BC (2005) Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis. Arch Neurol 62:1620–1623

    Article  PubMed  Google Scholar 

  8. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64:1270–1272

    CAS  PubMed  Google Scholar 

  9. Monson NL, Cravens PD, Frohman EM, Hawker K, Racke MK (2005) Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis. Arch Neurol 62:258–264

    Article  PubMed  Google Scholar 

  10. Heininger K, Hendricks M, Toyka KV, Kolb H (1983) Myasthenia gravis: remission not induced by blocking anti-idiotype antibodies. Muscle Nerve 6:386–387

    Article  CAS  PubMed  Google Scholar 

  11. (2006) www fda gov/cder/drug/InfoSheets/HCP/rituximab pdf

Download references

Author information

Authors and Affiliations

  1. Institute for MS research, Medical Faculty, University of Göttingen and Gemeinnützige Hertie-Stiftung, 37073, Göttingen, Germany

    A. Chan MD, D.-H. Lee MD, R. Linker MD & R. Gold MD

  2. Dept. of Neurology, Ruhr University St. Josef-Hospital, Gudrunstr. 56, 44791, Bochum, Germany

    A. Chan MD, D.-H. Lee MD, R. Linker MD & R. Gold MD

  3. Dept. of Neuroradiology, Medical Faculty, University of Göttingen, 37073, Göttingen, Germany

    A. Mohr MD

  4. Dept. of Neurology, Clinical Research Group for Multiple Sclerosis and Neuroimmunology Julius-Maximilians-University, 97080, Würzburg, Germany

    K. V. Toyka MD

Authors
  1. A. Chan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D.-H. Lee MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Linker MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Mohr MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. V. Toyka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Gold MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Gold MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chan, A., Lee, DH., Linker, R. et al. Rescue therapy with anti-CD20 treatment in neuroimmunologic breakthrough disease. J Neurol 254, 1604–1606 (2007). https://doi.org/10.1007/s00415-007-0593-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-007-0593-9

Keywords

Search

Navigation